Table 3.
EQ-5D | PROMIS | SCS-M | SCI-QOL | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
QALY | VAS | Physical | Mental | Sum Score | # SHCs | Pain Interference | PAWB | Anxiety | Depression | Resilience | Ability to Participate | ||
NON | Mean | 0.90 | 84.7 | 46.39 | 49.34 | 3.55 | 2.45 | 45.92 | 60.61 | 48.40 | 44.17 | 46.98 | 54.86 |
SD | 0.018* | 2.43* | 4.47 | 4.04 | 5.38 | 3.14 | 6.30 | 5.99 | 8.27 | 6.65 | 11.89 | 7.22 | |
SCI | Mean | 0.29 | 80.1 | 38.51 | 47.94 | 13.78 | 8.48 | 52.93 | 58.21 | 50.04 | 47.66 | 56.19 | 46.94 |
SD | 0.028* | 3.68* | 4.63 | 4.63 | 7.29 | 3.60 | 8.30 | 6.50 | 7.24 | 7.94 | 7.11 | 6.33 | |
P | <0.001 | 0.307 | <0.001 | 0.30 | <0.001 | <0.001 | 0.0032 | 0.22 | 0.49 | 0.12 | 0.0050 | <0.001 | |
Effect | 7.68 | 1.76 | −1.90 | −1.92 | 1.10 | ||||||||
Size | |||||||||||||
Power | 1.00 | 1.00 | 1.00 | 1.00 | 0.91 | ||||||||
QUAD | Mean | 0.19 | 77.64 | 35.80 | 47.05 | 13.82 | 8.36 | 51.97 | 57.44 | 51.02 | 48.12 | 54.48 | 43.69 |
SD | 0.027* | 6.83* | 2.78 | 5.41 | 6.01 | 2.98 | 8.06 | 5.96 | 7.52 | 9.13 | 6.03 | 4.16 | |
PARA | Mean | 0.38 | 82.42 | 41.00 | 48.76 | 13.75 | 8.58 | 53.80 | 58.93 | 49.15 | 47.24 | 57.76 | 49.93 |
SD | 0.031* | 3.49* | 4.67 | 3.85 | 8.56 | 4.23 | 8.77 | 7.14 | 7.18 | 7.07 | 7.91 | 6.65 | |
P | <0.001 | 0.54 | 0.00414 | 0.40 | 0.98 | 0.89 | 0.61 | 0.59 | 0.55 | 0.80 | 0.27 | 0.010 | |
Effect | 1.72 | 1.11 | |||||||||||
Size | |||||||||||||
Power | 0.98 | 0.72 |
Data shown for participants with and without SCI (top rows) and for SCI participants with quadriplegia (QUAD) vs. paraplegia (PARA)(bottom rows). Bonferroni-adjusted alpha (12 contrasts) = 0.004167. Effect size and statistical power are given for significant between-group comparisons.
SE shown to facilitate comparisons to EQ-5D normative values, which were published as mean/SE